Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)
Acute myeloid leukemia (AML) is a malignant hematological tumor with disordered oncogenes/tumor suppressor genes and limited treatments. The potent anti-cancer effects of bromodomain and extra-terminal domain (BET) inhibitors, targeting the key component of super enhancers, in early clinical trials...
Main Authors: | Ziyang Cao, Yi Shu, Jinxia Wang, Chunxia Wang, Tienan Feng, Li Yang, Jingbo Shao, Lin Zou |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2022-11-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304222000484 |
Similar Items
-
KRAS (G12D) Cooperates with AML1/ETO to Initiate a Mouse Model Mimicking Human Acute Myeloid Leukemia
by: Shanmin Zhao, et al.
Published: (2014-01-01) -
Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins
by: Juan Zhang, et al.
Published: (2021-09-01) -
Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter
by: Stephanie Sendker, et al.
Published: (2021-05-01) -
Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance
by: Caixia Han, et al.
Published: (2021-04-01) -
Microsatellite instability and cytogenetic survey in myeloid leukemias
by: E.M.S.F. Ribeiro, et al.
Published: (2002-02-01)